Skip to main content

Advertisement

Table 1 Summary of reported cases of LVF post pericardiocentesis: Clinical characteristics

From: A case report of ventricular dysfunction post pericardiocentesis: stress cardiomyopathy or pericardial decompression syndrome?

Report Age/Gender Clinical Scenario Chronicity of effusion Type of pericardi-ocentesis Nature of pericardial fluid Fluid drained Time to onset of symptoms Symptom Signs
VanDyke (1983) [5] 42 M Unwell for 10 days Days P Exudate (malignant) 680 mls Minutes Dyspnoea LVF
Shenoy (1984) [22] 57 M Recent myocardial infarction Days P Transudate 1000 mls Minutes Dyspnoea LVF
Glasser (1988) [23] 33 M Respiratory tract infection 3 months prior, history of Down’s and Ventricular Septal Defect Weeks S Transudate 2000 mls Minutes Dyspnoea LVF
Downey (1991) [24] 50 M Traumatic (3 weeks post motor vehicle accident) Weeks P Not specified 450 mls then 1500 mls Minutes Dyspnoea LVF
Wolfe (1993) [19] 46 F 2 weeks, history of breast cancer prior Weeks P Exudate 650 mls Weeks Dyspnoea LVF
Wolfe (1993) [19] 50 F 2 weeks, history of breast cancer prior Weeks P Exudate 650 mls Weeks Dyspnoea LVF
Hamaya (1993) [25] 16 F Unwell, lymphoma with pericardial effusion for 3 years Months P Not specified 700 mls Weeks Dyspnoea CS, and no APO
Braverman (1994) [26] 27 F Unwell for 3 weeks (Atrial Septal Defect closure 13 years prior) Weeks P then S Transudate 500 mls then 100 mls Days Dyspnoea, pleuritic chest pain LVF, RVF, CS
Anguera (1996) [27] 68 F History of bowel cancer, anorexia and dyspnoea for 1 month Weeks P Malignant 800 mls Minutes - CS
Sunday (1999) [8] 60 F 3 days of dyspnoea, lung cancer with pericardial involvement Days S Exudate 700 mls Minutes Dyspnoea CS, LVF
Chamoun (2003) [6] 36 F 2 months post Mitral valve replacement and Tricuspid repair Days P Exudate 1070 mls Hours Dyspnoea CS, LVF
Chamoun (2003) [6] 46 F Metastatic cancer Weeks P Exudate 1000 mls Hours Dyspnoea CS, LVF
Geffroy (2004) [7] 53 M 1 month post chemotherapy for cancer Weeks S Exudate 1500 mls Not specified Dyspnoea, hypoxia CS, LVF, RVF
Ligero (2006) [20] 41 F Lung cancer with hepatic metastases Days P Exudate 1000 mls Hours Dyspnoea LVF, RHF
Bernal (2007) [28] 45 F Acute myeloid leukemia Days P Exudate 500 mls Hours Dyspnoea CS, LVF
Dosios (2007) [9] 66 F Hematoma, 10 day history of dyspnoea Days S Exudate 500 mls initially Hours - CS
Sevimli (2008) [17] 42 F Infective - tuberculous pericarditis Days S Exudate 500 mls Hours Dyspnoea CS and LVF
Khalili (2008) [29] 32 F 2 months post aortic and mitral valve replacement surgery Weeks P Transudate 1000 mls Hours Dyspnoea CS
Flores (2009) [30] 80 M Unwell for weeks, multiple myeloma, stent 2 weeks prior Weeks P Transudate 1200mls Days Dyspnoea CS and LVF
Karamichalis (2009) [31] 19 F 2 months post motor vehicle accident Weeks P Exudate 1600 mls Hours Dyspnoea LVF
Lee (2010) [18] 14 M Infective – tuberculous pericarditis Days P Exudate Not specified Hours Dyspnoea CS, LVF
Lim (2011) [32] 44 F Hypothyroidism related heart failure. Dyspnoea and fatigue for 4 months Weeks S Exudate 1.3L 9 h - CS
Abdelsalam (2012) [10] 65 F Stage IV Non small cell lung cancer for 6 months, 1 week of dyspnoea Weeks S Malignant Complete drainage of pericardial effusion intraoperatively Seconds Asystole during surgery CS
Weijers (2013) [11] 69 F Weight loss and dyspnoea - P - 800 mls 6 h - LVF
Liang (2014) [1] 56 F Polymyositis. Progressive dyspnoea on exertion - P - 275 mls initially, with ongoing drain Several hours Pleuritic chest pain Nil
Versaci (2015) [16] 78 F 3 months post mitral valve repair Days P Possibly transudate 500 mls Hours Dyspnoea LVF
  1. Abbreviations: P percutaneous, S surgical, CS cardiogenic shock (hypotension, tachycardia), LVF Left heart failure, RVF right heart failure